Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. United States/
    2. Real-World Study Confirms Benefit of XARELTO® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients

    Real-World Study Confirms Benefit of XARELTO® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients

    December 9, 2022
    December 9, 2022

    Download the PDF